In March 2017 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after her sample tested positive for the prohibited substance Heptaminol.

After notification the Athlete gave a prompt admission, waived her right to be heard and accepted the provisional suspension and the sanction proposed by the CCES.

Therefore the CCES decides on 12 June 2017 to impose a 2 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 18 February 2017.

In May 2017 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after her sample tested positive for the prohibited substance Cannabis in a concentration above the WADA threshold. After notification the Athlete admitted the violation, waived her right to be heard, accepted the provisional suspension and the sanction proposed by the CCES.

The CCES established that the Athlete was not at significant fault or negligence for the violation and when tested the Athlete was not a International athlete as defined under the Rules. The Athlete’s use of Cannabis occurred out-of-competition prior to the sample collection.

Therefore the CCES decides on 5 June 2017 to impose a 2 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 11 May 2017.

In May 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substance Meldonium in a concentration above the WADA threshold and collected under the Rules on 8 May 2016. After notification a provisional suspension was ordered and hereafter the Athlete failed to respond to the CCES.

Due to the Athlete failed to dispute the asserted violation within the deadline under the Rules follows that the Athlete is deemed to have admitted the violation, to have waived his right for a hearing and to have accepted the sanction proposed by the CCES.

Therefore the CCES decides on 12 April 2012 to impose a 4 year period of ineligibility on the Athlete starting on 10 August 2010.

In April 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after her samples tested positive for the prohibited substance Cannabis.
After notification the Athlete gave a prompt admission, waived her right to be heard accepted the provisional suspension and the sanction proposed by the CCES.

The CCES established that the young Athlete was not at significant fault or negligence for the violation and when tested the Athlete was not a National or International athlete as defined under the Rules. The Athlete’s use of Cannabis occurred out-of-competition and weeks prior to the sample collection.

Therefore the CCES decides on 6 June 2016 to impose a 2 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 19 March 2016.

In April 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substances SARM S-22, Ibutamoren and Clenbuterol.

After notification the Athlete gave a prompt admission, waived his right to be heard and accepted the provisional suspension and the sanction proposed by the CCES.

Therefore on 14 June 2016 the CCES decides to impose a 4 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 23 March 2016.

In March 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substance Metandienone.

After notification the Athlete gave a prompt admission, waived his right to be heard, accepted the provisional suspension and the sanction proposed by the CCES.
The Athlete claimed that the supplement Jack-3D provided by a friend must have contained the substance Metandienone.

The CCES considers that the Athlete gave a prompt admission and waived his right to be heard and finds that the Athlete failed to produce evidence for his claim. Without a hearing the CCES can’t establish the Athlete’s degree of fault and how the prohibited substance came into his system.

Therefore on 26 June 2016 the CCES decides to impose a 3 year and 10 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 15 April 2016.

In October 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his sample tested positive for the prohibited substance cocaine.

After notification the Athlete failed to dispute the asserted violation within the deadline under the Rules follows that the Athlete is deemed to have admitted the violation, to have waived his right for a hearing and to have accepted the sanction proposed by the CCES.

Therefore the CCES decides on 12 April 2012 to impose a 4 year period of ineligibility on the Athlete starting on 29 March 2017.

In October 2016 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his sample tested positive for the prohibited substances Dexamphetamine (D-amphetamine, dextroamphetamine) and Levoamphetamine (L-amphetamine).

After notification the Athlete admitted the violation, waived his right to be heard, accepted the provisional suspension and the sanction proposed by the CCES.

The CCES established that the Athlete was at significant fault or negligence for the violation and the substance was used not intentionally and out-of-competition for academic purposes without a prescription.

Therefore the CCES decides on 21 December 2016 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 November 2016.

In August 2015 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the minor Athlete after his sample tested positive for the prohibited substance Salbutamol in a concentration above the WADA threshold.

After notification the Athlete admitted the violation, waived his right to be heard and accepted the sanction proposed by the CCES.

The CCES established that the Athlete was not at significant fault or negligence for the violation. When tested the Athlete was not a National or International athlete as defined under the Rules and at all times he used the medication Salbutamol as prescribed by his physician.

Therefore the CCES decides on 10 December 2015 to impose a reprimand on the minor Athlete without a period of ineligibility.

In June 2015 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete Curtis Moss after his sample tested positive for the prohibited substance Methylphenidate.

After notification the Athlete gave a prompt admission, waived his right to be heard and accepted the sanction proposed by the CCES. The Athlete explained that he had used the substance as medication prescribed by his physician and applied for a TUE which was approved by the CCES.

The CCES established that the Athlete was not at significant fault or negligence for the violation and decides on 14 December 2015 to impose a 2 month period of ineligibility on the Athlete starting on 4 January 2016.